Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2010
10/21/2010WO2010121010A2 Methods for inhibiting starvation of a cell
10/21/2010WO2010120524A2 Methods of modulating an immune response to a viral infection
10/21/2010WO2010120385A1 pH SENSITIVE BIODEGRADABLE POLYMERIC PARTICLES FOR DRUG DELIVERY
10/21/2010WO2010120266A1 Hpv particles and uses thereof
10/21/2010WO2010119698A1 Head-and-neck tumor proliferation inhibitor
10/21/2010WO2010119583A1 Polymer-nucleic acid complex, method for imaging tumor cells or the like using same, and pharmaceutical composition for treatment of cancer
10/21/2010WO2010119256A1 Composition for delivery of genetic material
10/21/2010WO2010118832A2 Inhibition of the liver enriched protein foxa2 for the treatment of colorectal liver metastases
10/21/2010US20100268329 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
10/21/2010US20100267941 Irna agents with biocleavable tethers
10/21/2010US20100267816 Human anti-amyloid beta peptide antibody and fragment of said antibody
10/21/2010US20100267813 Oligomeric Compounds And Compositions For Use In Modulation Of Small Non-Coding RNAs
10/21/2010US20100267812 Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
10/21/2010US20100267808 Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same
10/21/2010US20100267618 Methods for treating congestive heart failure
10/21/2010US20100267586 siRNA targeting KRAS
10/21/2010US20100267146 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell
10/21/2010US20100267140 Soluble inhibitors of vascular endothelial growth factor and use thereof
10/21/2010US20100267129 Chimeric nucleic acids encoding polypeptides comprising domains of tnf family ligands
10/21/2010US20100267121 Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates
10/21/2010US20100267118 Recombinational cloning using nucleic acids having recombination sites
10/21/2010US20100267046 Isoform-selective inhibitor and activators of pde3 cyclic nucleotide phosphodiesterases
10/21/2010US20100266633 Aids virus vaccines using sendai virus vector
10/21/2010US20100266630 Recombinant MVA virus, and the use thereof
10/21/2010US20100266564 Polyunsaturated Fatty Acid Synthase Nucleic Acid Molecules and Polypeptides, Compositions, and Methods of Making and Uses Thereof
10/21/2010US20100266547 Methods and compositions for treatment of interferon-resistant tumors
10/21/2010US20100266546 Selectively replicating viral vectors
10/21/2010US20100266533 Death Domain Containing Receptors
10/21/2010CA2795906A1 Hpv particles and uses thereof
10/20/2010EP2241623A2 Monoclonal antibody against a human cytokine receptor
10/20/2010EP2241572A2 Modulation of survivin expression
10/20/2010EP2241333A1 Therapeutic agent for mll leukemia and moz leukemia of which molecular target is m-csf receptor, and use thereof
10/20/2010EP2241330A1 Contraceptive methods and compositions related to proteasomal interference
10/20/2010EP2241329A2 Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness
10/20/2010EP2241308A2 Method for coating fine particle with lipid membrane
10/20/2010EP2240583A2 Wound healing compositions and treatments
10/20/2010EP2240508A1 Secretable hiv entry inhibitory peptides for therapy of hiv infection
10/20/2010EP1633890B1 METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF FNAi
10/20/2010EP1418941B9 Inducted immune response against the feline immunodeficiency virus
10/20/2010EP1383513B1 Tumor therapy with sindbis virus-based vectors
10/20/2010EP1366366B1 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
10/20/2010EP0710280B1 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
10/20/2010CN101868251A Pharmaceutical containing HIF-1alpha alpha and HIF-2alpha alpha expression inhibitor
10/20/2010CN101864452A Double-specificity anti-tumor recombinant adenovirus and construction method and application thereof
10/20/2010CN101864442A Artificial chromosome transfer vector for recombinant herpesvirus-of-turkey bacteria
10/20/2010CN101864434A Sheep aphthovirus Asial type multi-epitope recombinant vaccine and preparation method thereof
10/20/2010CN101864421A Structure and application of target programmed cell death protein 5 (PDCD5) anti-influenza virus oligonucleotide
10/20/2010CN101864400A Specific recombinant adenoviruses, preparation thereof and use thereof
10/20/2010CN101864078A Polyethyleneimine-chitosan-octadecanoic acid grafting, preparation and application
10/20/2010CN101864075A Preparation method of gene vector material of glucocorticoid-modifying polyethyleneimine
10/20/2010CN101863965A Helicobacter pylori urease B antigenic epitope polypeptide and application thereof
10/20/2010CN101863964A Helicobacter pylori urease B antigen epitope polypeptide and application thereof
10/20/2010CN101863963A Helicobacter pylori antigen epitope polypeptide and application thereof
10/20/2010CN101862459A Treatment of proliferative diseases using an antisense iap oligomer and chemotherapeutic agent
10/20/2010CN101862448A Immune protection effect of AFP (Alpha Fetoprotein) gene modified dendritic cell tumor vaccine to primary liver cancer genesis and development
10/20/2010CN101518655B Application of human interleukin-24 gene recombined vector mediated by adenovirus in preparing tumor analgesic medicament
10/20/2010CN101361983B Lung cancer DNA plasmid vaccine and preparation method thereof
10/20/2010CN101028524B Supersonic microvesicle target positioning controlled-release/gene device and target transferring method
10/19/2010US7816516 Reacting hydroxyalkyl starch (HAS) with the bioactive agent in a medium that includes water; drug-HAS conjugates for treating tumors, arrythmia, infectious diseases; bioavailability; nontoxic solvents; biodrug activity is not inactivated
10/19/2010US7816508 DNA active as a modified vaccinia virus Ankara promoter or active as a promoter in vaccinia virus infected cells; expression cassettes having coding sequence codes for therapeutic proteins or peptides, antigens, antigenic epitopes, antisense RNA or ribozymes; vaccines; genetic vectors; avipoxviruses;
10/19/2010US7816337 Drug delivery; to decrease cellular toxicity and improve efficacy
10/19/2010US7816335 Therapeutic compounds and methods
10/19/2010US7816334 Nucleic acid construct and nucleic acid expression vectors directing expression of a fusion protein consisting of a disease peptide antigen and a first domain of FrC of tetanus toxin; vaccines
10/19/2010US7816333 nucleosides such as 3',5'-di-O-Benzyl-2'-O,4'-C-ethylene-4-N-benzoylcytidine for treatment of pain, psoriasis, inflammatory disorders, infectious skin disease, skin cancer, Lyme disease, influenza virus, cytomegalovirus, herpes virus, herpes simplex virus, papilloma virus, Epstein Barr virus or HIV
10/19/2010US7816319 Methods and products for manipulating uncoupling protein expression
10/19/2010US7816136 Supporting cell differentiation in culture with a genetical modified cells; use for gene therapy; supporters being genetically modified in order to provide externally regulatable interactions between the supporters and the stem cells; supporters and stem cells are interchangeable upon modification
10/19/2010US7816131 Polynucleotide construct having a prostate cancer-specific control sequence including at least 2 of a prostate tissue-specific control sequence; a cancer-specific control sequence; and a two-step transcriptional amplification sequence including a DNA binding domain and an activation domain
10/19/2010US7816104 Packaging cells for recombinant adenovirus
10/19/2010US7816097 Nucleic acid sequence coding Mammastatin; protein useful in diagnosis, therapy fo breast cancer ; antigrowth agents
10/19/2010US7816075 treating a human afflicted with condition characterized by elevated serum triglyceride or very low density lipoprotein (VLDL), comprising the step of administering an inhibitor of human delta-9 stearoyl-CoA desaturase (SCD1) activity; coronary artery disease, Type II diabetes, obesity
10/19/2010US7815920 Method of preparing an antigen-containing formulation
10/19/2010US7815909 human tumor necrosis factor alpha (TNF) inhibitors; for rheumatoid arthritis, psoriatic arthritis or ankylosing spondilitis
10/19/2010US7815907 Antibodies to insulin-like growth factor I receptor
10/19/2010CA2495298C Use of antisense oligonucleotides to inhibit the expression of akt-1
10/19/2010CA2458853C Use of fucans in the treatment of adhesions, arthritis and psoriasis
10/19/2010CA2429138C Sol-fusin: use of gp64-6his to catalyze membrane fusion
10/19/2010CA2400667C Modified nodavirus rna for gene delivery
10/19/2010CA2390526C Sequence specific dna recombination in eukaryotic cells
10/19/2010CA2296704C Cardiac muscle regeneration using mesenchymal stem cells
10/19/2010CA2218251C Coding sequences of the human brca1 gene
10/19/2010CA2186118C Compacted nucleic acids and their delivery to cells
10/19/2010CA2147499C Prostate-specific membrane antigen
10/17/2010CA2701052A1 Method of cancer treatment
10/14/2010WO2010118045A1 Transcriptome transfer produces cellular phenotype conversion
10/14/2010WO2010117829A2 Differentially expressed micrornas as biomarkers for the diagnosis and treatment of sjögren's syndrome
10/14/2010WO2010117423A2 A METHOD FOR TREATING A PATIENT HAVING OR AT RISK FOR DEVELOPING A DISORDER ASSOCIATED WITH DECREASED EXPRESSION OF ß2 ADRENERGIC RECEPTORS OR NEED FOR INCREASED ß2 ADRENERGIC RECEPTOR ACTIVITY
10/14/2010WO2010117071A1 Ubiquitin fusion gene, and dna vaccine using same
10/14/2010WO2010117055A1 Polypeptide having selective inhibitory activity on protein kinase cα or η
10/14/2010WO2010116926A1 Tumor-specific promoter and use thereof
10/14/2010WO2010116899A1 Phosphorylation-inhibiting agent or dephosphorylating agent for pten
10/14/2010WO2010116673A1 Mitochondrial function-improving agent
10/14/2010WO2010116375A1 Isolated peptides for regulating apoptosis
10/14/2010WO2010116258A1 Neuron generation, regeneration and protection
10/14/2010WO2010065085A3 Methods and compositions for treating or preventing pruritis
10/14/2010WO2010062966A3 Methods for inducing mixed chimerism
10/14/2010WO2010045369A3 Fas/fasl or other death receptor targeted methods and compositions for killing tumor cells
10/14/2010US20100261880 Ly6h polypeptide
10/14/2010US20100261782 Intra-vascular kidney gene therapy with plasmid encoding bmp-7
10/14/2010US20100261778 Tumor Suppressor Killin
10/14/2010US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods
1 ... 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 ... 870